When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IDNA - ACADIA Pharmaceuticals: The Worst-Case Scenario For Investors
iShares Genomics Immunology and Healthcare
In my last article titled “ACADIA: The company perspectives in numbers”, I described the demographic trends that the company is operating under, listed key near-term catalysts, and made an overview of the company’s development. However, in the comments to the article, I noticed investor interest in the company’s valuations and price target. Thus, I decided to perform a valuation of the company’s existing segment for PDP treatment with its marketed medication NUPLAZID, as well as take a look at the 10-year horizon for the company segment under different assumptions and 3 scenarios.